Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine, will participate in Cure’s virtual fireside chat, “Racing to Cures: US–China Biomedical Competitiveness,” on July 27 from 10:00 to 11:00 PM Beijing Time. (IMAGE)

InSilico Medicine

Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine, will participate in Cure’s virtual fireside chat, “Racing to Cures: US–China Biomedical Competitiveness,” on July 27 from 10:00 to 11:00 PM Beijing Time.

Caption

The discussion will explore the competitive landscape and areas of collaboration between the United States and China in biomedical innovation.

Credit

Insilico Medicine & Cure

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.